It is the tenth leading cause of death and is projected to become the fifth most common cause of death by 2050
Moreover, mitochondria-targeted antioxidant Mito-Tempo alleviates diabetic tubular injury and TECs apoptosis by reducing mitochondrial double-stranded RNA release and inhibiting the activation of the PKR/eIF2 signaling pathway (109), indicating that mitochondria quality control dysfunction is a significant upstreaming point in regulating apoptosis
Comprehensive lab testing to assess hormone levels and ensure the right approach Expert medical guidance to personalize dosing and maximize effectiveness Prescription-grade peptides sourced from trusted, regulated pharmacies Ongoing supervision to track progress and adjust as needed Our Services We offer a wide range of services to support your overall wellness, including: Hormone Optimization Weight Loss Cellular & Functional Medicine Precision Longevity HeartFit Program Sexual Enhancement Peptide Therapy HOCATT Our Locations Were here to support you wherever you are
As its popularity grows, so does the awareness of potential side effects
Clinical Trial Results The clinical trial SURMOUNT-5 (NCT05822830) of adults with obesity who did not have type 2 diabetes demonstrated that Zepbound patients had an average weight loss of 50.3 lbs (22.8 kg), which was 20.2% of their body weight, and a 7.2-inch ( 18.4 cm) reduction in waist circumference, at 72 weeks